A system view and analysis of essential hypertension

Objectives: The goal of this study was to investigate genes associated with essential hypertension from a system perspective, making use of bioinformatic tools to gain insights that are not evident when focusing at a detail-based resolution. Methods: Using various databases (pathways, Genome Wide Association Studies, knockouts etc.), we compiled a set of about 200 genes that play a major role in hypertension and identified the interactions between them. This enabled us to create a protein–protein interaction network graph, from which we identified key elements, based on graph centrality analysis. Enriched gene regulatory elements (transcription factors and microRNAs) were extracted by motif finding techniques and knowledge-based tools. Results: We found that the network is composed of modules associated with functions such as water retention, endothelial vasoconstriction, sympathetic activity and others. We identified the transcription factor SP1 and the two microRNAs miR27 (a and b) and miR548c-3p that seem to play a major role in regulating the network as they exert their control over several modules and are not restricted to specific functions. We also noticed that genes involved in metabolic diseases (e.g. insulin) are central to the network. Conclusion: We view the blood-pressure regulation mechanism as a system-of-systems, composed of several contributing subsystems and pathways rather than a single module. The system is regulated by distributed elements. Understanding this mode of action can lead to a more precise treatment and drug target discovery. Our analysis suggests that insulin plays a primary role in hypertension, highlighting the tight link between essential hypertension and diseases associated with the metabolic syndrome.

[1]  G. Heinze,et al.  Proteomic-Biostatistic Integrated Approach for Finding the Underlying Molecular Determinants of Hypertension in Human Plasma , 2017, Hypertension.

[2]  Jie Zheng,et al.  An update on genome-wide association studies of hypertension , 2015, Applied Informatics.

[3]  E. Schiff,et al.  Factors that predict the development of hypertension in women with pregnancy induced hypertension , 2015 .

[4]  A. Dominiczak,et al.  Genetic and molecular aspects of hypertension. , 2015, Circulation research.

[5]  S. Textor Secondary hypertension: renovascular hypertension. , 2014, Journal of the American Society of Hypertension : JASH.

[6]  F. Marques,et al.  The emerging role of non-coding RNA in essential hypertension and blood pressure regulation , 2014, Journal of Human Hypertension.

[7]  F. Liu,et al.  Glucocorticoids Transcriptionally Regulate miR-27b Expression Promoting Body Fat Accumulation Via Suppressing the Browning of White Adipose Tissue , 2014, Diabetes.

[8]  Youwen Liu,et al.  miR-27 inhibits adipocyte differentiation via suppressing CREB expression. , 2014, Acta biochimica et biophysica Sinica.

[9]  F. Messerli,et al.  Secondary arterial hypertension: when, who, and how to screen? , 2014, European heart journal.

[10]  Andreas Krämer,et al.  Causal analysis approaches in Ingenuity Pathway Analysis , 2013, Bioinform..

[11]  Zhi-yuan Yu,et al.  Sp1 trans-activates and is required for maximal aldosterone induction of the αENaC gene in collecting duct cells. , 2013, American journal of physiology. Renal physiology.

[12]  Chang-gong Liu,et al.  miRNA-548c: a specific signature in circulating PBMCs from dilated cardiomyopathy patients. , 2013, Journal of molecular and cellular cardiology.

[13]  G. Vanpoucke,et al.  Integrated Proteomics Pipeline Yields Novel Biomarkers for Predicting Preeclampsia , 2013, Hypertension.

[14]  Jing Wang,et al.  WEB-based GEne SeT AnaLysis Toolkit (WebGestalt): update 2013 , 2013, Nucleic Acids Res..

[15]  J. Mehta,et al.  MicroRNAs Involved in the Regulation of Postischemic Cardiac Fibrosis , 2013, Hypertension.

[16]  Lei Deng,et al.  PrePPI: a structure-informed database of protein–protein interactions , 2012, Nucleic Acids Res..

[17]  Jun-ichi Satoh,et al.  Molecular network analysis of human microRNA targetome: from cancers to Alzheimer’s disease , 2012, BioData Mining.

[18]  D. Karolina,et al.  Circulating miRNA profiles in patients with metabolic syndrome. , 2012, The Journal of clinical endocrinology and metabolism.

[19]  I. McGonnell,et al.  Expression of guanylyl cyclase-B (GC-B/NPR2) receptors in normal human fetal pituitaries and human pituitary adenomas implicates a role for C-type natriuretic peptide. , 2012, Endocrine-Related Cancer.

[20]  P. Sethupathy,et al.  Abstract 24: MicroRNA-27b Is a Regulatory Hub in Lipid Metabolism and Is Altered in Dyslipidemia , 2012, Arteriosclerosis, Thrombosis, and Vascular Biology.

[21]  Andrea Knau,et al.  MicroRNA-27a/b controls endothelial cell repulsion and angiogenesis by targeting semaphorin 6A. , 2012, Blood.

[22]  T. Coffman,et al.  Under pressure: the search for the essential mechanisms of hypertension , 2011, Nature Medicine.

[23]  I. Maruyama,et al.  Quantitative peptidomic analysis by a newly developed one‐step direct transfer technology without depletion of major blood proteins: Its potential utility for monitoring of pathophysiological status in pregnancy‐induced hypertension , 2011, Proteomics.

[24]  E. Olson,et al.  Regulation of angiogenesis and choroidal neovascularization by members of microRNA-23∼27∼24 clusters , 2011, Proceedings of the National Academy of Sciences.

[25]  Damian Szklarczyk,et al.  The STRING database in 2011: functional interaction networks of proteins, globally integrated and scored , 2010, Nucleic Acids Res..

[26]  Jesmin,et al.  Gene regulatory network reveals oxidative stress as the underlying molecular mechanism of type 2 diabetes and hypertension , 2010, BMC Medical Genomics.

[27]  Marcin Piechota,et al.  Identification of cis-Regulatory Elements in the Mammalian Genome: The cREMaG Database , 2010, PloS one.

[28]  Jean-Stéphane Varré,et al.  TFM-Explorer: mining cis-regulatory regions in genomes , 2010, Nucleic Acids Res..

[29]  C. Dani,et al.  microRNA miR-27b impairs human adipocyte differentiation and targets PPARgamma. , 2009, Biochemical and biophysical research communications.

[30]  Kwang-Hyun Cho,et al.  Hub genes with positive feedbacks function as master switches in developmental gene regulatory networks , 2009, Bioinform..

[31]  Jianping Ye,et al.  A role of miR‐27 in the regulation of adipogenesis , 2009, The FEBS journal.

[32]  S. G. Lima,et al.  Renin-angiotensin system: is it possible to identify hypertension susceptibility genes? , 2007, Arquivos brasileiros de cardiologia.

[33]  Brad T. Sherman,et al.  The DAVID Gene Functional Classification Tool: a novel biological module-centric algorithm to functionally analyze large gene lists , 2007, Genome Biology.

[34]  J. Saavedra The challenge of genetic studies in hypertension. , 2007, Circulation research.

[35]  M. Gerstein,et al.  Getting connected: analysis and principles of biological networks. , 2007, Genes & development.

[36]  I. King Jordan,et al.  A Family of Human MicroRNA Genes from Miniature Inverted-Repeat Transposable Elements , 2007, PloS one.

[37]  E. Porteri,et al.  A prospective study of the prevalence of primary aldosteronism in 1,125 hypertensive patients. , 2006, Journal of the American College of Cardiology.

[38]  A. Cowley The genetic dissection of essential hypertension , 2006, Nature Reviews Genetics.

[39]  P. Guyenet The sympathetic control of blood pressure , 2006, Nature Reviews Neuroscience.

[40]  Weihong Yan,et al.  Expression-based monitoring of transcription factor activity: the TELiS database , 2005, Bioinform..

[41]  D. Gardner,et al.  Transcriptional Regulation of Type B Human Natriuretic Peptide Receptor Gene Promoter: Dependence on Sp1 , 2004, Hypertension.

[42]  George Howard,et al.  Insulin Resistance and Hypertension: The Insulin Resistance Atherosclerosis Study , 2004, Hypertension.

[43]  N. Abate,et al.  The metabolic syndrome and uric acid nephrolithiasis: novel features of renal manifestation of insulin resistance. , 2004, Kidney international.

[44]  P. Shannon,et al.  Cytoscape: a software environment for integrated models of biomolecular interaction networks. , 2003, Genome research.

[45]  P. Munroe,et al.  Genes and hypertension. , 2003, Current pharmaceutical design.

[46]  J. Sowers,et al.  Interactive effects of insulin-like growth factor-1 and beta-estradiol on endothelial nitric oxide synthase activity in rat aortic endothelial cells. , 2003, Metabolism: clinical and experimental.

[47]  M. Klagsbrun,et al.  Characterization of the neuropilin‐1 promoter; gene expression is mediated by the transcription factor Sp1 , 2003, Journal of cellular biochemistry.

[48]  Tom H. Pringle,et al.  The human genome browser at UCSC. , 2002, Genome research.

[49]  F. Messerli,et al.  Diabetes, hypertension, and cardiovascular disease: an update. , 2001, Hypertension.

[50]  J. Sowers,et al.  Vascular insulin/insulin-like growth factor-1 resistance in female obese Zucker rats. , 2001, Metabolism: clinical and experimental.

[51]  M. Flesch,et al.  On the trail of cardiac specific transcription factors. , 2001, Cardiovascular research.

[52]  Q. Xu,et al.  Sp1 Increases Expression of Cyclooxygenase-2 in Hypoxic Vascular Endothelium , 2000, The Journal of Biological Chemistry.

[53]  Albert,et al.  Emergence of scaling in random networks , 1999, Science.

[54]  G. Nickenig,et al.  Insulin induces upregulation of vascular AT1 receptor gene expression by posttranscriptional mechanisms. , 1998, Circulation.

[55]  K. Siddle,et al.  Phosphoinositide 3-kinase: the key switch mechanism in insulin signalling. , 1998, The Biochemical journal.

[56]  J. Sowers,et al.  Insulin and insulin-like growth factor in normal and pathological cardiovascular physiology. , 1997, Hypertension.

[57]  R. Muniyappa,et al.  Insulin-like growth factor I diminishes in vivo and in vitro vascular contractility: role of vascular nitric oxide. , 1996, Endocrinology.

[58]  G. Reaven,et al.  Hypertension and associated metabolic abnormalities--the role of insulin resistance and the sympathoadrenal system. , 1996, The New England journal of medicine.

[59]  M. Romo,et al.  Hyperinsulinemia in Normotensive Offspring of Hypertensive Parents , 1994, Hypertension.

[60]  A. Lever Angiotensin II, angiotensin-converting enzyme inhibitors, and blood vessel structure. , 1992, The American journal of medicine.

[61]  Richard Barnett Diabetes , 1904, The Lancet.

[62]  Andrew D. Johnson,et al.  Integrative network analysis reveals molecular mechanisms of blood pressure regulation. , 2015, Molecular systems biology.

[63]  Anton J. Enright,et al.  Network visualization and analysis of gene expression data using BioLayout Express3D , 2009, Nature Protocols.

[64]  Brad T. Sherman,et al.  Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources , 2008, Nature Protocols.

[65]  Cynthia M. Lakon,et al.  How Correlated Are Network Centrality Measures? , 2008, Connections.

[66]  J. Hokanson,et al.  The Insulin Resistance Atherosclerosis Study Family Study , 2004 .

[67]  A. Baron,et al.  Vascular reactivity. , 1999, The American journal of cardiology.